Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.

Bostanci EB, Ozer I, Ercan M, Ulas M, Koc U, Karaman K, Dalgic T, Ozogul Y, Akoglu M.

Hepatogastroenterology. 2013 May;60(123):624-7.

PMID:
23635437
2.
3.

Comparison of complications after D2 and D3 dissection for gastric cancer.

Bostanci EB, Kayaalp C, Ozogul Y, Aydin C, Atalay F, Akoglu M.

Eur J Surg Oncol. 2004 Feb;30(1):20-5.

PMID:
14736518
4.

Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.

Chen JH, Cai SR, Zhai ET, Chen SL, Wu KM, Song W, He YL.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14365-73. eCollection 2015.

5.

The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.

Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR, Douglass HO Jr.

J Am Coll Surg. 1995 Jul;181(1):56-64.

PMID:
7599772
6.

Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.

Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N.

Anticancer Res. 2000 Mar-Apr;20(2B):1285-9.

PMID:
10810436
7.

Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons.

Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata S, Yamamoto H, Kim BS, Matsuki N, Sawa T, Noh SH; East Asia Surgical Oncology Group.

Hepatogastroenterology. 2006 May-Jun;53(69):389-94.

PMID:
16795979
8.

[D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].

Vasilescu C, Herlea V, Tidor S, Ivanov B, Stănciulea O, Mănuc M, Gheorghe C, Ionescu M, Diculescu M, Popescu I.

Chirurgia (Bucur). 2006 Jul-Aug;101(4):375-84. Romanian.

PMID:
17059148
9.

Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.

Alatengbaolide, Lin D, Li Y, Xu H, Chen J, Wang B, Liu C, Lu P.

Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.

PMID:
22547011
10.

Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.

Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A; Polish Gastric Cancer Study Group.

Am J Surg. 2007 Jan;193(1):10-5.

PMID:
17188080
11.

Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.

Volpe CM, Driscoll DL, Douglass HO Jr.

Ann Surg Oncol. 2000 Mar;7(2):139-44.

PMID:
10761793
12.

[Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].

Di Martino N, Izzo G, Cosenza A, Vicenzo L, Monaco L, Torelli F, Basciotti A, Brillantino A, Marra A.

Suppl Tumori. 2005 May-Jun;4(3):S84-5. Italian.

PMID:
16437920
13.

Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.

Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH.

J Surg Oncol. 2013 Jun;107(8):807-14. doi: 10.1002/jso.23325. Epub 2013 Mar 19.

PMID:
23512524
14.

Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?

Eom BW, Joo J, Kim YW, Park B, Park JY, Yoon HM, Lee JH, Ryu KW.

Ann Surg Oncol. 2013 Aug;20(8):2669-75. doi: 10.1245/s10434-013-2938-1. Epub 2013 Mar 30.

PMID:
23543195
15.

Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.

Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B.

Ann Surg. 2011 May;253(5):900-11. doi: 10.1097/SLA.0b013e318212bff6. Review.

PMID:
21394009
16.

Open vs robot-assisted laparoscopic gastric resection with D2 lymph node dissection for adenocarcinoma: a case-control study.

Caruso S, Patriti A, Marrelli D, Ceccarelli G, Ceribelli C, Roviello F, Casciola L.

Int J Med Robot. 2011 Dec;7(4):452-8. doi: 10.1002/rcs.416. Epub 2011 Oct 7.

PMID:
21984205
17.

Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.

Gunji Y, Suzuki T, Kobayashi S, Hori S, Hayashi H, Shimada H, Matsubara H, Nabeya Y, Ochiai T.

Hepatogastroenterology. 2003 Jul-Aug;50(52):1178-82.

PMID:
12846009
18.

Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.

Han FH, Zhou SN, Li HM, He YL, Zhan WH.

World J Gastroenterol. 2016 Apr 14;22(14):3813-20. doi: 10.3748/wjg.v22.i14.3813.

19.

Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?

Sun D, Gong R, Wu H.

Surg Oncol. 2012 Mar;21(1):e7-11. doi: 10.1016/j.suronc.2011.10.002. Epub 2011 Nov 8.

PMID:
22071221
20.

[The role of superextended lymphadenectomy (D4) in gastric cancer].

Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Di Lernia S, Boniardi M, Bramerio MA.

Minerva Chir. 2004 Aug;59(4):325-35. Italian.

PMID:
15278027

Supplemental Content

Support Center